482 related articles for article (PubMed ID: 26393347)
1. Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.
Hart BE; Hale LP; Lee S
PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004046. PubMed ID: 26393347
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine Efficacy.
Hart BE; Lee S
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005229. PubMed ID: 27941982
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected mice.
Roupie V; Pidot SJ; Einarsdottir T; Van Den Poel C; Jurion F; Stinear TP; Huygen K
PLoS Negl Trop Dis; 2014; 8(1):e2604. PubMed ID: 24392169
[TBL] [Abstract][Full Text] [Related]
4. Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer.
Tanghe A; Content J; Van Vooren JP; Portaels F; Huygen K
Infect Immun; 2001 Sep; 69(9):5403-11. PubMed ID: 11500410
[TBL] [Abstract][Full Text] [Related]
5. Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model.
Mangas KM; Buultjens AH; Porter JL; Baines SL; Marion E; Marsollier L; Tobias NJ; Pidot SJ; Quinn KM; Price DJ; Kedzierska K; Zeng W; Jackson DC; Chua BY; Stinear TP
Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31818964
[TBL] [Abstract][Full Text] [Related]
6. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
[TBL] [Abstract][Full Text] [Related]
8. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.
Bolz M; Bénard A; Dreyer AM; Kerber S; Vettiger A; Oehlmann W; Singh M; Duthie MS; Pluschke G
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004431. PubMed ID: 26849213
[TBL] [Abstract][Full Text] [Related]
10. Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
Fraga AG; Martins TG; Torrado E; Huygen K; Portaels F; Silva MT; Castro AG; Pedrosa J
PLoS One; 2012; 7(3):e33406. PubMed ID: 22413022
[TBL] [Abstract][Full Text] [Related]
11. Structural basis and designing of peptide vaccine using PE-PGRS family protein of Mycobacterium ulcerans-An integrated vaccinomics approach.
Nain Z; Karim MM; Sen MK; Adhikari UK
Mol Immunol; 2020 Apr; 120():146-163. PubMed ID: 32126449
[TBL] [Abstract][Full Text] [Related]
12. Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease.
Bolz M; Kerber S; Zimmer G; Pluschke G
PLoS Negl Trop Dis; 2015; 9(8):e0004011. PubMed ID: 26275222
[TBL] [Abstract][Full Text] [Related]
13. Buruli ulcer.
Einarsdottir T; Huygen K
Hum Vaccin; 2011 Nov; 7(11):1198-203. PubMed ID: 22048117
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of a dewaxed whole-cell vaccine against Mycobacterium ulcerans infection in mice.
Watanabe M; Nakamura H; Nabekura R; Shinoda N; Suzuki E; Saito H
Vaccine; 2015 May; 33(19):2232-2239. PubMed ID: 25825332
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70.
Dai FY; Wang JF; Gong XL; Bao L
Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301284
[TBL] [Abstract][Full Text] [Related]
17. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
[TBL] [Abstract][Full Text] [Related]
18. Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting.
Tanghe A; Dangy JP; Pluschke G; Huygen K
PLoS Negl Trop Dis; 2008 Mar; 2(3):e199. PubMed ID: 18350112
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer.
Coutanceau E; Legras P; Marsollier L; Reysset G; Cole ST; Demangel C
Microbes Infect; 2006 Jul; 8(8):2075-81. PubMed ID: 16781179
[TBL] [Abstract][Full Text] [Related]
20. Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis.
Pérez de Val B; Villarreal-Ramos B; Nofrarías M; López-Soria S; Romera N; Singh M; Abad FX; Xing Z; Vordermeier HM; Domingo M
Clin Vaccine Immunol; 2012 Sep; 19(9):1339-47. PubMed ID: 22761299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
